Back
EAPC Premium Access

Cardiovascular pharmacology - Poster discussant:

Session: Poster Session 3 - Cardiovascular pharmacology
Topic: Other
Event: EuroPrevent 2018

Congress Presentation

Add to my library

Like

4 more presentations in this session

Adverse effects of drug therapy (the first results of the study according to the outpatient register)

Speaker: Doctor Y. Lukina (Moscow, RU)

Access
Abstract
Slides
Like
Thumbnail

Improving adherence to medicines of secondary prevention - results of a prospective multicenter follow-up study

Access
Like
Thumbnail

Alirucumab in cardiac rehabilitation patients. Clinical profile and initial results.

Speaker: Doctor A. Rojas Sanchez (Malaga, ES)

Access
Abstract
Slides
Like
Thumbnail

Statins and risk biomarkers for coronary heart disease (CHD) in type 2 diabetes mellitus patients with normal LDL cholesterol levels. 1 year prospective study in Constanta County, Romania

Speaker: Professor I. Parepa (Constanta, RO)

Access
Abstract
Like
Thumbnail

Access the full session

Poster Session 3 - Cardiovascular pharmacology

Speakers: Doctor Y. Lukina, Doctor A. Rojas Sanchez, Professor I. Parepa
Access
Like
Thumbnail

About the event

Image

EuroPrevent 2018

19 April - 21 April 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources